Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Gut Microbiota and Autism Spectrum Disorder: A Neuroinflammatory Mediated Mechanism of Pathogenesis? Publisher



Zarimeidani F1 ; Rahmati R1 ; Mostafavi M2 ; Darvishi M3 ; Khodadadi S5 ; Mohammadi M6 ; Shamlou F7 ; Bakhtiyari S8 ; Alipourfard I9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Students Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran
  2. 2. Faculty of Allied Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. School of Aerospace and Subaquatic Medicine, Infectious Diseases & amp
  4. 4. Tropical Medicine Research Center (IDTMC), AJA University of Medical Sciences, Tehran, Iran
  5. 5. Student Research Committee, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
  6. 6. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  7. 7. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  8. 8. Feinberg Cardiovascular and Renal Research Institute, North Western University, Chicago, IL, United States
  9. 9. Institute of Physical Chemistry, Polish Academy of Sciences, 01-224, Marcin Kasprzaka 44/52, Warsaw, Poland

Source: Inflammation Published:2024


Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social communication and behavior, frequently accompanied by restricted and repetitive patterns of interests or activities. The gut microbiota has been implicated in the etiology of ASD due to its impact on the bidirectional communication pathway known as the gut-brain axis. However, the precise involvement of the gut microbiota in the causation of ASD is unclear. This study critically examines recent evidence to rationalize a probable mechanism in which gut microbiota symbiosis can induce neuroinflammation through intermediator cytokines and metabolites. To develop ASD, loss of the integrity of the intestinal barrier, activation of microglia, and dysregulation of neurotransmitters are caused by neural inflammatory factors. It has emphasized the potential role of neuroinflammatory intermediates linked to gut microbiota alterations in individuals with ASD. Specifically, cytokines like brain-derived neurotrophic factor, calprotectin, eotaxin, and some metabolites and microRNAs have been considered etiological biomarkers. We have also overviewed how probiotic trials may be used as a therapeutic strategy in ASD to reestablish a healthy balance in the gut microbiota. Evidence indicates neuroinflammation induced by dysregulated gut microbiota in ASD, yet there is little clarity based on analysis of the circulating immune profile. It deems the repair of microbiota load would lower inflammatory chaos in the GI tract, correct neuroinflammatory mediators, and modulate the neurotransmitters to attenuate autism. The interaction between the gut and the brain, along with alterations in microbiota and neuroinflammatory biomarkers, serves as a foundational background for understanding the etiology, diagnosis, prognosis, and treatment of autism spectrum disorder. Graphical Abstract: (Figure presented.) © The Author(s) 2024.
Other Related Docs
11. Prebiotics and Probiotics and Parkinson's Disease, Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders (2023)
12. Gut Microbiota: A Perspective for Bipolar Disorders, Gastrointestinal Nursing (2024)